Browsing: trials

A once-a-month GLP-1/GIP drug candidate moves into US trials, signaling a new phase for metabolic medicine and longevity investing. Could…

Company’s osteoporosis program completes enrollment in Phase 2 trial focused on treating the disease in postmenopausal women. US biotech Angitia…

Altimmune raises $75 million to advance pemvidutide, a promising therapy tackling serious liver and metabolic diseases. For most, liver disease…

Credit: Keith Chambers / Getty Images / Science Photo Library Targeting specific mutations during meningioma therapy is feasible and useful,…

Scribe’s CRISPR-based cholesterol reduction therapy is part of a three-pronged approach to combating cardiovascular disease. Genetic medicine biotech Scribe Therapeutics…

Credit: JDawnInk / Getty Images / DigitalVision Vectors A new analysis from researchers at UC Riverside and UC Irvine found…

Two controversial research studies assessing the risks and benefits of giving puberty blockers to young people with gender incongruence will…

A brain–computer interface developed by neurotechnology firm Paradromics contains electrodes that record from neurons in the cerebral cortex and then…

Europe’s health commissioner has warned that “unnecessary clinical trials” and bureaucracy are “not sending the right message” to the pharmaceutical…

Credit: Yuichiro Chino/Getty Images In a development that could significantly improve treatment outcomes for patients with heart failure and other…